Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Mar;4(2):202–207. doi: 10.1128/cdli.4.2.202-207.1997

Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.

P von Zons 1, P Crowley-Nowick 1, D Friberg 1, M Bell 1, U Koldovsky 1, T L Whiteside 1
PMCID: PMC170502  PMID: 9067656

Abstract

Natural killer (NK) and lymphokine-activated killer (LAK) cell activities were measured in peripheral blood obtained from healthy women to compare a standard 51Cr release assay with a nonradioactive europium (Eu3+) release assay based on time-resolved fluorescence. The two types of cytotoxicity assays were first compared in paired determinations performed on 28 samples of peripheral blood mononuclear cells obtained from healthy women who had normal pap smears or no biopsy evidence of cervical squamous intraepithelial lesions (SIL). Target cells (NK-sensitive K562 and NK-resistant Raji cell lines) were labeled with Eu3+ only, 51Cr only, or both labels and compared in cytotoxicity assays using fresh or interleukin 2 (IL-2)-activated effector cells. Spontaneous release in the Eu3+ release assay was comparable to that observed in the 51Cr release assay, but maximum Eu3+ release always exceeded that of 51Cr. In 4-h assays, specific release of Eu3+ from target cells was more rapid than that of 51Cr, consistently resulting in 30 to 40% higher levels of activity. However, a significant linear correlation (P < 0.001) was observed between cytotoxicity levels based on measurements of Eu3+ and 51Cr release in 4-h assays. The Eu3+ release assay was then used to measure NK and LAK activities in the peripheral blood of women with cervical SIL or cervical squamous cell carcinoma (SCC). Mean NK activity of women with advanced SIL (121 lytic units [LU]) or SCC (93 LU) was found to be similar to that of controls (101 LU) or patients with normal cervical biopsies (90 LU), as was the ability to generate IL-2-stimulated NK activity. However, LAK activity during 18 h of incubation in the presence of IL-2 was reduced in patients with cervical SCC (P < 0.05) compared with that in normal controls. Results of 51Cr assays performed in parallel with patient samples gave comparable results. Advantages of EU3+ release assays for routine evaluation of cytotoxicity are discussed.

Full Text

The Full Text of this article is available as a PDF (277.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomberg K., Granberg C., Hemmilä I., Lövgren T. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J Immunol Methods. 1986 Feb 12;86(2):225–229. doi: 10.1016/0022-1759(86)90457-6. [DOI] [PubMed] [Google Scholar]
  2. Blomberg K., Granberg C., Hemmilä I., Lövgren T. Europium-labelled target cells in an assay of natural killer cell activity. II. A novel non-radioactive method based on time-resolved fluorescence. significance and specificity of the method. J Immunol Methods. 1986 Aug 21;92(1):117–123. doi: 10.1016/0022-1759(86)90511-9. [DOI] [PubMed] [Google Scholar]
  3. Blomberg K. Simultaneous measurement of natural killer cell cytotoxicity against each of three different target cell lines. J Immunol Methods. 1994 Feb 10;168(2):267–273. doi: 10.1016/0022-1759(94)90064-7. [DOI] [PubMed] [Google Scholar]
  4. Blomberg K., Ulfstedt A. C. Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. J Immunol Methods. 1993 Mar 15;160(1):27–34. doi: 10.1016/0022-1759(93)90005-r. [DOI] [PubMed] [Google Scholar]
  5. Bohlen H., Manzke O., Engert A., Hertel M., Hippler-Altenburg R., Diehl V., Tesch H. Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation. J Immunol Methods. 1994 Jul 12;173(1):55–62. doi: 10.1016/0022-1759(94)90283-6. [DOI] [PubMed] [Google Scholar]
  6. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968 Feb;14(2):181–196. [PMC free article] [PubMed] [Google Scholar]
  7. Bryant J., Day R., Whiteside T. L., Herberman R. B. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods. 1992 Jan 21;146(1):91–103. doi: 10.1016/0022-1759(92)90052-u. [DOI] [PubMed] [Google Scholar]
  8. Granberg C., Blomberg K., Hemmilä I., Lövgren T. Determination of cytotoxic T lymphocyte activity by time-resolved fluorometry using europium-labelled concanavalin A-stimulated cells as targets. J Immunol Methods. 1988 Nov 10;114(1-2):191–195. doi: 10.1016/0022-1759(88)90173-1. [DOI] [PubMed] [Google Scholar]
  9. Hemmilä I., Dakubu S., Mukkala V. M., Siitari H., Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem. 1984 Mar;137(2):335–343. doi: 10.1016/0003-2697(84)90095-2. [DOI] [PubMed] [Google Scholar]
  10. Heo D. S., Park J. G., Hata K., Day R., Herberman R. B., Whiteside T. L. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res. 1990 Jun 15;50(12):3681–3690. [PubMed] [Google Scholar]
  11. Larsen N. S. Invasive cervical cancer rising in young white females. J Natl Cancer Inst. 1994 Jan 5;86(1):6–7. doi: 10.1093/jnci/86.1.6. [DOI] [PubMed] [Google Scholar]
  12. Lövgren J., Blomberg K. Simultaneous measurement of NK cell cytotoxicity against two target cell lines labelled with fluorescent lanthanide chelates. J Immunol Methods. 1994 Jul 12;173(1):119–125. doi: 10.1016/0022-1759(94)90289-5. [DOI] [PubMed] [Google Scholar]
  13. Maley D. T., Simon P. Cytotoxicity assays using cryopreserved target cells pre-labeled with the fluorescent marker europium. J Immunol Methods. 1990 Nov 6;134(1):61–70. doi: 10.1016/0022-1759(90)90112-9. [DOI] [PubMed] [Google Scholar]
  14. Parkin D. M., Lärä E., Muir C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988 Feb 15;41(2):184–197. doi: 10.1002/ijc.2910410205. [DOI] [PubMed] [Google Scholar]
  15. Pross H. F., Baines M. G., Rubin P., Shragge P., Patterson M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981 Jan;1(1):51–63. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  16. Schiffman M. H., Bauer H. M., Hoover R. N., Glass A. G., Cadell D. M., Rush B. B., Scott D. R., Sherman M. E., Kurman R. J., Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993 Jun 16;85(12):958–964. doi: 10.1093/jnci/85.12.958. [DOI] [PubMed] [Google Scholar]
  17. Soini E., Kojola H. Time-resolved fluorometer for lanthanide chelates--a new generation of nonisotopic immunoassays. Clin Chem. 1983 Jan;29(1):65–68. [PubMed] [Google Scholar]
  18. Vaquer S., Jordá J., López de la Osa E., Alvarez de los Heros J., López-García N., Alvarez de Mon M. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1990 Jan;36(1):90–92. doi: 10.1016/0090-8258(90)90114-z. [DOI] [PubMed] [Google Scholar]
  19. Volgmann T., Klein-Struckmeier A., Mohr H. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J Immunol Methods. 1989 Apr 21;119(1):45–51. doi: 10.1016/0022-1759(89)90379-7. [DOI] [PubMed] [Google Scholar]
  20. Whiteside T. L., Bryant J., Day R., Herberman R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J Clin Lab Anal. 1990;4(2):102–114. doi: 10.1002/jcla.1860040207. [DOI] [PubMed] [Google Scholar]
  21. Whiteside T. L., Herberman R. B. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol. 1994 Mar;1(2):125–133. doi: 10.1128/cdli.1.2.125-133.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES